Johns Hopkins University — Washington D.C., District of Columbia

Johns Hopkins University is a clinical research site located in Washington D.C., District of Columbia, United States 20016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Johns Hopkins University has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Johns Hopkins University?

Johns Hopkins University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Johns Hopkins University conducted?

Johns Hopkins University has 1 clinical trials on record, with 1 currently active. Their work covers Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors.

Is Johns Hopkins University accredited by Crixeo Health?

Johns Hopkins University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Johns Hopkins University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.